At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02359 WUXI APPTEC
Market Closed 12-20 16:08:10
55.100
+0.200
+0.36%
High55.550
Low54.400
Vol3.01M
Open54.900
D1 Closing54.900
Amplitude2.09%
Mkt Cap159.13B
Tradable Cap21.32B
Total Shares2.89B
T/O165.38M
T/O Rate0.78%
Tradable Shares387.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
BRIEF-JPMorgan Chase & Co's Long Position In H-Shares Of Wuxi Apptec Decreases To 9.93% On Dec 12 - HKEX
WuXi AppTec Co., Ltd. is a China-based investment holding company principally engaged in the provision of new drug research and development (R&D), production and supporting services, as well as related technology platform services. The Company is mainly engaged in the discovery, development and production of small molecule drugs, cell therapies and gene therapies, as well as providing testing services for medical devices. The Company mainly conducts its businesses through four segments, including China-based Laboratory Services segment, Contract Manufacturing organization/contract development and manufacturing organization services (CMO/CDMO services) segment, US-based Laboratory Services segment and Clinical Research segment.